Member Info for FeverClucker

errr running late????

Poor old Ssccss (whatever!) and his de-ramping short mate sterling, George and the other halfwits.

This is excellent news, and for all those that **** Vlad off - HE invented it!! He may not be the best in corporate finance and PR but HE KNOWS WHAT HE KNOWS. GL to all those accumulating and ignoring the bullS41t.

Many thanks minded/wally - now registered - lets hope its exciting news....

bamb - Is that the right link? I've just logged in and it says no up and coming meetings?

Thank you bamb

Is there a link for tonights presentation please anyone?

Many thanks

Thanks CM - was this in IC? Could you post article if you have or summarise for me please?
Not sure if Corporation Financière Européenne S.A will bid again, but any bid would need to be a lot closer to NAV. Noticeable that investments in Circassia, HSS Hire Vertu Motors and Brave Bison have all been performing better. Ixico investments also look shrewd move to me. GL

Agricore, I do agree with your analysis and think this is very undervalued. When was STs last commentary on this as I may have missed?

Thanks

I wonder why? People beginning to understand big discount to NAV, will re rate soon with some nice investments. Any views??

Very insightful!

Lots of nonsense on here, takeover etc. Lot of uninformed twaddle

if you are watching and pondering a buy, now is the time IMHO

Could this one be going back to sub 50P like many other COVID P&D? Looks like market becoming impatient with all these stocks...

Hi Sam, I was going to ask the same thing. Seems a bit strange so soon after main IPO.

Another great piece of news, down to 11p today then :-(

Sorry but this is a waste of time

thank you robs12

easp or anyone - can you post IC article or snippet please?

Thanks

88.25p this is so undervalued it’s ridiculous

Excellent indeed:

The Board has continued to demonstrate its confidence in the ongoing success of the business throughout the period under review and post-period end. I have elected to receive most of my remuneration in share options and collectively we remain confident that the Company's shares should deliver significant shareholder return over the long term.

Shareholders may have confidence that the Company's prospects remain excellent. My fellow directors and I continue to look forward to the realisation of Hemogenyx Pharmaceuticals' great potential to deliver rewards both to shareholders in the form of increased value and to our target patients and society at large as a life-saving company.